Johnson & Johnson (J&J) is asking the U.S. Food and Drug Administration (FDA) to approve a combination of two medications, Tecvayli (teclistamab) and…
Myeloma
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Latest news
Discussion
A caregiver’s energy is a rare currency. When we spend it, we’re not doing so in single, large transactions. Instead, we’re making thousands of tiny…
Most people with hard-to-treat myeloma were still alive and free from disease progression two years after treatment with anito-cel (anitocabtagene autoleucel), an experimental cell…
Discussion
As I write this, yesterday was Tuesday. Perhaps it was a great day for someone who got a promotion or received a gift. But for…
Most myeloma patients who started treatment at the Berenson Cancer Center — a clinic in California that specializes in myeloma care — lived…
Discussion
Ever since my mum was diagnosed with myeloma, I’ve had to rewrite my vocabulary. My days are no longer filled with deadlines and projects,…
